Value of total tumor load as a clinical and pathological factor in the prognosis of breast cancer patients receiving neoadjuvant treatment. Comparison of three populations with three different surgical approaches: NEOVATTL Pro 3 Study.
María Dolores Martín-SalvagoMagdalena SanchoM Ángeles López-GarcíaAlicia Cano JiménezAna Pérez-LuqueLina AlfaroBegoña VieitesPublished in: Breast cancer research and treatment (2023)
No significant differences in DFS were observed between three centers with different surgical approaches to ALND based on different TTL cut-offs in patients with BC after NAST. These results suggest that restricting ALND to those patients with TTL ≥ 15,000 copies/μL is a reliable approximation, avoiding unnecessary morbidities caused by ALND.